|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-1-25
|
|
pubmed:abstractText |
Anaplastic thyroid cancer is an endocrine malignancy. Its rare and rapidly lethal disease course has made it challenging to study. Little is known regarding the expression by anaplastic tumors of molecular targets for new human anticancer agents that have been studied in the preclinical or clinical setting. The objective of this work was to evaluate the expression profile of anaplastic thyroid tumors for molecular targets for treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
719-29
|
|
pubmed:dateRevised |
2011-7-11
|
|
pubmed:meshHeading |
pubmed-meshheading:17115102-Aged,
pubmed-meshheading:17115102-Carcinoma,
pubmed-meshheading:17115102-Cyclin D1,
pubmed-meshheading:17115102-Cyclin E,
pubmed-meshheading:17115102-Female,
pubmed-meshheading:17115102-Gene Expression Profiling,
pubmed-meshheading:17115102-Humans,
pubmed-meshheading:17115102-Male,
pubmed-meshheading:17115102-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:17115102-Protein-Serine-Threonine Kinases,
pubmed-meshheading:17115102-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17115102-Thyroid Neoplasms,
pubmed-meshheading:17115102-Tumor Markers, Biological,
pubmed-meshheading:17115102-beta Catenin
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.
|
|
pubmed:affiliation |
Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada. smwiseman@providencehealth.bc.ca
|
|
pubmed:publicationType |
Journal Article
|
